Levetiracetam Neuraxpharm

Levetiracetam, the active ingredient in Levetiracetam Neuraxpharm, is an anticonvulsant (pyrrolidine derivative) presented as an oral tablet for oral use. It is used to treat partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability in various seizure types. - Partial‑onset seizures: reduces the frequency of focal seizure episodes. - Generalized tonic‑clonic seizures: helps prevent convulsive seizures in generalized epilepsy. - Myoclonic seizures: decreases myoclonic jerks in appropriate epilepsy syndromes.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe skin reactions such as Stevens‑Johnson syndrome - Suicidal thoughts or behavior - Severe depression or mood changes - Blood dyscrasias (e.g., neutropenia, thrombocytopenia) - Hypersensitivity reactions including anaphylaxis - Multi‑organ involvement (e.g., hepatic or renal impairment)

Levetiracetam requires careful monitoring in certain patient groups and clinical situations. - Renal impairment: adjust dose based on renal function. - History of psychiatric disorders: monitor for mood changes. - Concomitant CNS depressants: assess additive sedation. - Pregnancy: use only if benefit outweighs risk. - Elderly patients: start at lower dose and titrate slowly. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Levetiracetam can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenytoin: may decrease levetiracetam exposure. - Phenobarbital: may lower levetiracetam concentrations. - Rifampin: induces metabolism, reducing efficacy. - Other enzyme‑inducing antiepileptics: may diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression. - Sedative antihistamines: may increase drowsiness. - Opioids: monitor for enhanced sedation. - CNS depressants (e.g., benzodiazepines): watch for excessive sedation. - Oral contraceptives: levetiracetam may reduce efficacy; consider alternative contraception.